Klonopin (Clonazepam): Dependence, Withdrawal, and Recovery Support

Klonopin (clonazepam) is the second most prescribed benzodiazepine in the United States. Of the roughly 92 million benzodiazepine prescriptions dispensed in 2019, 24 percent were for clonazepam, behind only alprazolam (FDA, 2020). It was built for seizures and panic, and it lasts a long time in the body, which is what fools people: you can miss a dose, feel fine, and get hit a week later. Dependence can develop within weeks at prescribed doses, and stopping suddenly can cause seizures. This page covers what dependence looks like, why Klonopin withdrawal arrives late and stays long, how a safe taper works, how testing handles it, and how weekly support at home fits in.

What Klonopin is and how it works

Clonazepam is a benzodiazepine approved for two things. The label says it "is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures," and that it "is indicated for the treatment of panic disorder, with or without agoraphobia" (Klonopin prescribing information, Indications). Like every benzodiazepine, it enhances "the activity of gamma aminobutyric acid (GABA), the major inhibitory neurotransmitter" (prescribing information), which turns the brain's volume down: calm and drowsiness at first, slurred speech, memory gaps, and an unsteady walk at higher doses (DEA). Klonopin "contains clonazepam, a Schedule IV controlled substance" (prescribing information).

It comes as 0.5 mg, 1 mg, and 2 mg tablets and as generic clonazepam. On the street it is "k-pins," "pins," or just "benzos"; the DEA lists "benzos" and "downers" as the slang for the class (DEA). Most counterfeit pills mimic oxycodone but "can also mimic hydrocodone, alprazolam (Xanax), Adderall, and other medications," and they often contain "lethal amounts of fentanyl or methamphetamine" (DEA, 2021). In 2025 alone the DEA seized more than 47 million fentanyl-laced counterfeit pills (DEA, One Pill Can Kill).

Two features matter for anyone trying to stop. First, the elimination half-life is "typically 30 to 40 hours" (prescribing information, Clinical Pharmacology), roughly three times the 11 hours reported for alprazolam (Xanax prescribing information, section 12.3). Levels fall slowly, so withdrawal arrives days later than with Xanax and runs longer. Second, it treats the two conditions where fear of stopping is most rational. Nobody wants a seizure or a panic attack back, so people stay on it long after the original reason has faded, even though "up to 30% of patients who initially responded have shown a loss of anticonvulsant activity, often within 3 months" (prescribing information). Tolerance is built in.

Dependence, misuse, and addiction are not the same thing

People treat these as one word, and it creates shame that does not belong. The label defines physical dependence as "a state that develops as a result of physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction" (prescribing information, Drug Abuse and Dependence). The FDA's 2020 class warning adds the timeline: "Physical dependence can occur when benzodiazepines are taken steadily for several days to weeks, even as prescribed" (FDA, 2020). It happens to people who never took one extra tablet.

Misuse is taking it other than as prescribed: more, more often, or from someone else's bottle. Addiction, a sedative use disorder in clinical language, is the pattern the label describes as "a strong desire to take the drug, difficulties in controlling drug use (e.g., continuing drug use despite harmful consequences, giving a higher priority to drug use than other activities and obligations)" (prescribing information). Someone can be dependent without being addicted. Someone can be addicted at 1 mg a day. The useful question is not the milligrams but what the pill has started to cost.

Signs Klonopin has become a problem

These are what members and families describe most often. Anxiety or shakiness several days after a missed refill, when the person had assumed they were fine. Needing 2 mg where 0.5 mg used to work. An extra tablet before a flight, then before ordinary days. Foggy memory, slowed speech, or a fall nobody can quite explain. Using it to come down from stimulants or to sleep after drinking, the pattern the label flags because it "is associated with an increased frequency of serious adverse outcomes, including respiratory depression, overdose, or death" (prescribing information, Warnings). Running out early. Getting tablets from a friend or a website. And a quiet one families notice first: the calendar shrinking, because the person has stopped doing anything that might require feeling something.

Why you should not stop Klonopin cold turkey

If you take one thing from this page, take this. The boxed warning states that "abrupt discontinuation or rapid dosage reduction of Klonopin after continued use may precipitate acute withdrawal reactions, which can be life-threatening" (prescribing information, boxed warning). The patient guide is plainer: "Stopping KLONOPIN suddenly can cause seizures that will not stop (status epilepticus)" (Klonopin medication guide). Alcohol and benzodiazepines are the two drug classes where withdrawal itself can kill. The risk is higher for "those who take higher dosages, and those who have had longer durations of use" (prescribing information).

The long half-life adds a specific trap. Someone who stops can feel nothing for two or three days and conclude they were never dependent. Then the floor drops. In the case reports behind the 2020 boxed warning, withdrawal symptoms "lasted from weeks to years" (FDA, 2020). Anyone taking Klonopin daily for more than a few weeks needs a prescriber involved in stopping it.

Klonopin withdrawal timeline

Every taper is different. Timing depends on dose, duration, other substances, and how fast the dose comes down. Because clonazepam is long-acting, the whole curve sits later and stretches longer than the one on our Xanax page.

Days 1 to 3: the quiet stretch

Often nothing, or a little more restlessness at night, because blood levels are still falling from a drug with a 30 to 40 hour half-life (prescribing information). The World Health Organization's withdrawal management guideline is direct about it: for long-acting benzodiazepines, "withdrawal typically begins 2-7 days after the last dose," compared with 1 to 2 days for short-acting ones (WHO, 2009). This is the window where people decide they are fine.

Days 3 to 10: the arrival

Symptoms build rather than snap on. The label's list of acute withdrawal signs includes "anxiety, blurred vision, depersonalization, depression, derealization, dizziness, fatigue," insomnia, "muscle pain and stiffness, panic attacks, photophobia, restlessness, tachycardia, and tremor" (prescribing information, Warnings). Seizure risk lives here if the dose was cut sharply. For someone who took it for panic, the panic comes back louder than it left; that is rebound, not proof the drug was working.

Weeks 2 to 4: the hardest part

In our experience this is where the strain peaks: broken sleep, senses turned up, a body that will not settle. The WHO guideline says withdrawal from long-acting benzodiazepines "continues for 2-8 weeks or longer" (WHO, 2009). This is when people take "just one" to make it stop, and it is why a gradual taper matters more than willpower.

Weeks 4 to 8 and beyond

Physical symptoms ease for most people. Mood and sleep lag behind. The label describes a protracted syndrome of "anxiety, cognitive impairment, depression, insomnia, formication, motor symptoms," tingling, and tinnitus "that persists beyond 4 to 6 weeks after initial benzodiazepine withdrawal," and says it "may last weeks to more than 12 months" (prescribing information). If that is you, it is not in your head, and it is the strongest argument for support that outlasts a detox stay.

How a safe taper works

There is no FDA-approved medication for benzodiazepine use disorder the way there is for opioids or alcohol. The treatment is a slow, supervised reduction. The label's own schedule for panic disorder is that "treatment should be discontinued gradually, with a decrease of 0.125 mg twice daily every 3 days, until the drug is completely withdrawn," and it tells prescribers that "if a patient develops withdrawal reactions, consider pausing the taper or increasing the dosage to the previous tapered dosage level" (prescribing information, Dosage and Administration). For someone on 1 mg twice a day, that is eight steps over about three and a half weeks at the fastest; most people we see go slower.

In 2025 the American Society of Addiction Medicine and nine other societies published a joint guideline on benzodiazepine tapering (ASAM, 2025). The parts most useful to a member or a family are these.

The pace is slow. Clinicians "should generally consider dose reductions of 5% to 10% when determining the initial pace of the BZD taper," and the pace "should typically not exceed 25% every 2 weeks" (ASAM, Recommendation 6). On 2 mg a day, the first step is 0.1 to 0.2 mg. Months is normal.

The taper can pause. When symptoms interfere, clinicians "should first consider pausing or slowing the pace of the BZD taper" before adding other medications (Recommendation 11).

Some people need a higher level of care. The guideline points to inpatient withdrawal management when there is imminent risk of serious harm, when other conditions make an outpatient taper unsafe, or when severe withdrawal is happening or expected (Recommendation 5). A seizure disorder, a past withdrawal seizure, high doses, and alcohol or opioids in the mix are the flags we hear most.

Support is part of the prescription. Clinicians "should offer patients undergoing BZD tapering behavioral interventions tailored to their underlying conditions (eg, CBT, CBT-I)" (Recommendation 10). That is where we spend our time. A taper on paper is simple; week five of it, at home, with a job and a brain that has forgotten how to sleep, is not.

Klonopin with alcohol, opioids, or other drugs

Benzodiazepines rarely kill on their own. They kill in combination. The first line of the boxed warning is that "concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death" (prescribing information, boxed warning). In the first half of 2020, "92.7% of benzodiazepine-involved deaths also involved opioids, and 66.7% involved illicitly manufactured fentanyls" across 38 states (CDC MMWR, 2021). In 2023, clonazepam was the 14th most frequently involved drug in U.S. overdose deaths, named in 1,976 of them, and alprazolam ranked fifth with fentanyl present in 68.4 percent of its deaths (CDC National Vital Statistics Reports, 2026).

Alcohol carries the same risk, and the FDA's advice is one sentence: "Do not drink alcohol with benzodiazepines" (FDA, 2020). Gabapentin, sleep medications, and muscle relaxants stack the same way. If someone you love takes Klonopin and drinks or uses any opioid, keep naloxone in the house. Narcan 4 mg nasal spray has been sold without a prescription since March 2023 (FDA, 2023). It reverses the opioid part of a mixed overdose only. Call 911 either way.

Drug testing for Klonopin

In theory clonazepam falls under the benzodiazepine line on any panel. In practice it is the benzodiazepine that quick screens miss most, because the body converts most of it to a metabolite, 7-aminoclonazepam, that reacts poorly with immunoassay antibodies. In a study of 180 pain patients prescribed clonazepam, the immunoassay called only 21 percent of their urine samples positive, while LC-MS/MS testing for the metabolite found 87 percent (West et al., Pain Physician, 2010). Saliva shows the same pattern: of 100 presumptive-positive oral fluid samples, 91 confirmed for 7-aminoclonazepam and 44 for clonazepam itself, with metabolite levels "approximately 2.4-fold higher" (Melanson et al., Clin Chim Acta, 2016).

Detection windows in saliva run longer than for Xanax. In people admitted to detox after heavy, repeated use, clonazepam was detectable in oral fluid for up to 5 days and 7-aminoclonazepam for up to 6, against 2.5 days for alprazolam (Nordal et al., Ther Drug Monit, 2015). Urine windows for the class run "3-7 days" after therapeutic dosing and "up to 30 days" with chronic use (SAMHSA TIP 47, Appendix B). A prescribed, tapering dose will test positive, which is expected; what matters is whether the result matches the plan. And a negative benzodiazepine result says nothing about what was in a pressed pill.

Our members use saliva-based screening that is assigned at random through the week. The instant 10-panel strip we use has a benzodiazepine line, but for the reasons above we do not lean on it for clonazepam. A member coming off Klonopin has their screening run as the lab-confirmed oral fluid test, where a CLIA-certified lab uses LC-MS/MS to report clonazepam by name at a 2 ng/mL cutoff. You do not choose whether you test; you choose who sees the results. For most members that means the prescriber managing the taper and, if they want, a spouse or parent. We explain the details in our guide to how sobriety monitoring works.

How recovery from Klonopin works with Accountable

We are not a detox and we do not prescribe. The taper belongs to your doctor. What we provide is the behavioral and psychosocial support the ASAM guideline calls for, delivered at home for as long as the taper and its aftermath take. It runs in three stages.

1. Get the full picture

In the first sessions your coach maps what is really going on: why it was started (seizures and panic are different conversations), how long, how much, what happened the last time you tried to cut back, and whether alcohol, opioids, gabapentin, or sleep medication are in the mix. Because clonazepam withdrawal shows up late, we ask about the week after a missed refill, not the day after. If you do not have a prescriber managing the taper, we help you find one, and with your permission we coordinate with them.

2. Build a plan that fits your life

A taper that requires you to quit your job or move back home is a taper you will abandon. Your coach helps you plan around the real calendar: which reductions to schedule ahead of a quiet week, what you will do at 3 a.m. when sleep will not come, who you will text before you call the old contact. If panic was the original diagnosis, the plan includes what you will reach for instead of the pill when it comes back. Daily peer group meetings and a weekly family Zoom group give the people around you their own place to get support.

3. Weekly check-ins through the long stretch

Clonazepam recovery takes longer than people expect, and the hardest weeks arrive after friends assume you are done. Your coach shows up every week through the taper and past it, and the lab-confirmed saliva screening turns "I think he's doing okay" into a shared record that you control. When a slip happens, and with Klonopin it tends to come in the third or fourth week, we treat it as information. The plan changes and the support goes up. Every coach at Accountable has their own recovery behind them.

Accountable is covered by a growing list of commercial health plans, with more added each month, and private-pay plans start at $375 per month. You can check your coverage in a few minutes or call the care team at (646) 450-7641. Families are welcome to make the first call; see our page for families.

Common questions

How long does Klonopin withdrawal last?

Later and longer than most benzodiazepines. Symptoms typically begin 2 to 7 days after the last dose and continue for 2 to 8 weeks or longer (WHO, 2009). Some people have a protracted syndrome lasting "weeks to more than 12 months" (prescribing information).

How long does Klonopin stay in your system?

The half-life is 30 to 40 hours (prescribing information), so a single dose takes about a week to clear. After heavy, repeated use, clonazepam has been found in saliva for up to 5 days and its metabolite for up to 6 (Nordal et al., 2015), and urine can stay positive for weeks with chronic use (SAMHSA TIP 47).

Can I taper off Klonopin at home?

Many people do, with a prescriber writing and adjusting the schedule. Whether home is safe depends on dose, duration, a seizure disorder or past withdrawal seizure, and whether alcohol or opioids are involved. The ASAM guideline lists those as reasons to consider a higher level of care (ASAM, 2025). Ask your doctor; do not design the taper yourself.

Will Klonopin show up on a drug test?

On a lab test, yes, for days after the last dose. On an instant benzodiazepine strip, not reliably: one study found the immunoassay caught 21 percent of prescribed users and LC-MS/MS 87 percent (West et al., 2010). If you have a prescription, a positive result is expected; what matters is that it matches the plan.

What should I do if someone on Klonopin will not wake up?

Call 911. If there is any chance opioids are involved, give naloxone. Keep them on their side and stay with them. Benzodiazepine overdose with opioids or alcohol is a medical emergency (prescribing information, boxed warning). For treatment referrals afterward, SAMHSA's free helpline is 1-800-662-4357 (SAMHSA).

Sources

• U.S. Food and Drug Administration. Klonopin (clonazepam) tablets, prescribing information and medication guide, 2023.

• U.S. Food and Drug Administration. Xanax (alprazolam) tablets, prescribing information, 2023.

• U.S. Food and Drug Administration. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. Drug Safety Communication, September 23, 2020.

• U.S. Food and Drug Administration. FDA Approves First Over-the-Counter Naloxone Nasal Spray. Press announcement, March 29, 2023.

• Drug Enforcement Administration. Benzodiazepines drug fact sheet.

• Drug Enforcement Administration. Counterfeit Pills fact sheet, May 2021.

• Drug Enforcement Administration. One Pill Can Kill.

• Liu S, O'Donnell J, Gladden RM, McGlone L, Chowdhury F. Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines, 38 States and the District of Columbia, 2019-2020. MMWR Morbidity and Mortality Weekly Report. 2021;70(34):1136-1141.

• Garnett MF, Cisewski JA, Ahmad FB. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017-2023. National Vital Statistics Reports. 2026;75(1).

• World Health Organization. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings, 2009.

• American Society of Addiction Medicine. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits, 2025.

• American Society of Addiction Medicine. Joint Clinical Practice Guideline on Benzodiazepine Tapering (full guideline PDF), 2025.

• Substance Abuse and Mental Health Services Administration. TIP 47, Appendix B: Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use, 2006.

• Substance Abuse and Mental Health Services Administration. SAMHSA's National Helpline.

• Nordal K, Øiestad EL, Enger A, Christophersen AS, Vindenes V. Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake. Therapeutic Drug Monitoring. 2015;37(4):451-460.

• Melanson SEF, Griggs D, Bixho I, Khaliq T, Flood JG. 7-Aminoclonazepam is superior to clonazepam for detection of clonazepam use in oral fluid by LC-MS/MS. Clinica Chimica Acta. 2016;455:128-133.

• West R, Pesce A, West C, et al. Comparison of Clonazepam Compliance by Measurement of Urinary Concentration by Immunoassay and LC-MS/MS in Pain Management Population. Pain Physician. 2010;13(1):71-78.